Mutations associated with anthelmintic drug resistance

Anti-Infective Agents in Medicinal Chemistry

Volumn 9, Issue 3, 2010, Pages 105-112

  Beech, R N ^a   Silvestre, A ^b  

^a MCGILL UNIVERSITY   (Canada)

^b UR1282   (France)

Author keywords

Anthelmintic resistance; Benzimidazole; Beta tubulin; Levamisole; Ligand gated ion channel; Macrocyclic lactone; Monepantel; Mutation; Praziquantel

Indexed keywords

ANTHELMINTIC AGENT; BENZIMIDAZOLE; BETA TUBULIN; CHLORIDE CHANNEL; ION CHANNEL; LEVAMISOLE; MACROLIDE; NICOTINIC RECEPTOR; PRAZIQUANTEL; VOLTAGE GATED CALCIUM CHANNEL;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BETA CHAIN; DRUG BINDING; DRUG RESPONSE; DRUG TARGETING; GENE MUTATION; IN VIVO STUDY; NONHUMAN; PARASITE CONTROL; POPULATION GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM; SPLICING DEFECT;

EID: 77954667884     PISSN: 18715214     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871521411009030105     Document Type: Article

References (78)

1. Gilleard, J. S.; Beech, R. N., Population genetics of anthelmintic resistance in parasitic nematodes. Parasitology, 2007, 134, 1133-47.
2. Kaplan, R. M., Drug resistance in nematodes of veterinary importance: a status report. Trends Parasitol., 2004, 20, 477-81.
3. Kohler, P., The biochemical basis of anthelmintic action and resistance. Int. J. Parasitol., 2001, 31, 336-45.
4. Kerboeuf, D.; Blackhall, W.; Kaminsky, R.; von Samson-Himmelstjerna, G., P-glycoprotein in helminths: function and perspectives for anthelmintic treatment and reversal of resistance. Int.J. Antimicrob. Agents, 2003, 22, 332-46.
5. Lanusse, C. E.; Prichard, R. K., Clinical pharmacokinetics and metabolism of benzimidazole anthelmintics in ruminants. DrugMetab. Rev., 1993, 25, 235-79.
6. Karadzovska, D.; Seewald, W.; Browning, A.; Smal, M.; Bouvier, J.; Giraudel, J. M., Pharmacokinetics of monepantel and its sulfone metabolite, monepantel sulfone, after intravenous and oral administration in sheep. J. Vet. Pharm. Ther., 2009, 32, 359-67.
7. Lacey, E.; Prichard, R. K., Interactions of benzimidazoles (BZ)with tubulin from BZ-sensitive and BZ-resistant isolates of Haemonchus contortus. Mol. Biochem. Parasitol., 1986, 19, 171-81.
8. Kwa, M. S. G.; Jetty, V. S.; Roos, M. H., Benzimidazole resistance in Haemonchus contortus is correlated with a conserved mutation at amino acid 200 in ß-tubulin isotype 1. Mol. Biochem. Parasitol.,1994, 63, 299-303.
9. Silvestre, A.; Cabaret, J., Mutation in position 167 of isotype 1beta-tubulin gene of Trichostrongylid nematodes: role in benzimidazole resistance? Mol. Biochem. Parasitol., 2002, 120, 297-300.
10. Beech, R. N.; Prichard, R. K.; Scott, M. E., Genetic variability of the beta-tubulin genes in benzimidazole-susceptible and -resistant strains of Haemonchus contortus. Genetics, 1994, 138, 103-10.
11. Elard, L.; Comes, A. M.; Humbert, J. F., Sequences of beta-tubulinc DNA from benzimidazole-susceptible and -resistant strains of Teladorsagia circumcincta, a nematode parasite of small ruminants. Mol. Biochem. Parasitol., 1996, 79, 249-53.
12. Elard, L.; Humbert, J. F., Importance of the mutation of amino acid200 of the isotype 1 beta-tubulin gene in the benzimidazole resistance of the small-ruminant parasite Teladorsagia circumcincta. Parasitol. Res., 1999, 85, 452-6.
13. Lubega, G. W.; Prichard, R. K., Interaction of benzimidazole anthelmintics with Haemonchus contortus tubulin: binding affinityand anthelmintic efficacy. Exp. Parasitol., 1991, 73, 203-213.
14. Lubega, G. W.; Prichard, R. K., Specific interaction of benzimida-zole anthelmintics with tubulin: high-affinity binding and benzimidazole resistance in Haemonchus contortus. Mol. Biochem. Parasitol., 1990, 38, 221-232.
15. Kwa, M.; Veenstra, J.; Van, D. M.; Roos, M., Beta-tubulin genesfrom the parasitic nematode Haemonchus contortus modulate drug resistance in Caenorhabditis elegans. J. Mol. Biol., 1995, 246, 500-510.
16. Ghisi, M.; Kaminsky, R.; Maser, P., Phenotyping and genotyping of Haemonchus contortus isolates reveals a new putative candidate mutation for benzimidazole resistance in nematodes. Vet. Parasi-tol., 2007, 144, 313-20.
17. Rufener, L.; Kaminsky, R.; Maser, P., In vitro selection of Haemonchus contortus for benzimidazole resistance reveals a mutation at amino acid 198 of beta-tubulin. Mol. Biochem. Parasitol., 2009,168, 120-2.
18. Robinson, M. W.; McFerran, N.; Trudgett, A.; Hoey, L.; Fairweather, I., A possible model of benzimidazole binding to beta-tubulin disclosed by invoking an inter-domain movement. J. Mol.Graph. Model, 2004, 23, 275-84.
19. Roos, M. H.; Boersema, J. H.; Borgsteede, F. H.; Cornelissen, J.; Taylor, M.; Ruitenberg, E. J., Molecular analysis of selection forbenzimidazole resistance in the sheep parasite Haemonchus contortus. Mol. Biochem. Parasitol., 1990, 43, 77-88.
20. Winterrowd, C. A.; Pomroy, W. E.; Sangster, N. C.; Johnson, S. S.;Geary, T. G., Benzimidazole-resistant beta-tubulin alleles in a population of parasitic nematodes (Cooperia oncophora) of cattle.Vet. Parasitol., 2003, 117, 161-72.
21. Njue, A. I.; Prichard, R. K., Cloning two full-length beta-tubulin isotype cDNAs from Cooperia oncophora, and screening for benzimidazole resistance-associated mutations in two isolates. Parasitology 2003, 127, 579-88.
22. Palcy, C.; Silvestre, A.; Sauve, C.; Cortet, J.; Cabaret, J., Benzimidazole resistance in Trichostrongylus axei in sheep: long-termmonitoring of affected sheep and genotypic evaluation of the para-site. Vet. J., 2010, 183, 68-74.
23. Silvestre, A.; Humbert, J. F., Diversity of benzimidazole-resistancealleles in populations of small ruminant parasites. Int. J. Parasitol.,2002, 32, 921-8.
24. Silvestre, A.; Métais, A.; Sauvé, C.; Cabaret, J., Résistance auxbenzimidazoles et complémentarité des single nucleotide polymor-phism SNP 167 et 200 de la tubuline des nématodes parasites. In Journées d'animation du Département de Santé Animale, Sei-gnosse, France, 2009.
25. von Samson-Himmelstjerna, G.; Harder, A.; Pape, M.; Schnieder, T., Novel small strongyle (Cyathostominae) beta-tubulin sequences. Parasitol. Res., 2001, 87, 122-5.
26. Drogemuller, M.; Schnieder, T.; von Samson-Himmelstjerna, G., Beta-tubulin complementary DNA sequence variations observed between cyathostomins from benzimidazole-susceptible and -resistant populations. J. Parasitol., 2004, 90, 868-70.
27. Hodgkinson, J. E.; Clark, H. J.; Kaplan, R. M.; Lake, S. L.; Matthews, J. B., The role of polymorphisms at beta tubulin isotype 1codons 167 and 200 in benzimidazole resistance in cyathostomins.Int. J. Parasitol., 2008, 38, 1149-60.
28. Clark, H. J.; Kaplan, R. M.; Matthews, J. B.; Hodgkinson, J. E., Isolation and characterisation of a beta tubulin isotype 2 gene from two species of cyathostomin. Int. J. Parasitol., 2005, 35, 349-58.
29. De Clercq, D.; Sacko, M.; Behnke, J.; Gilbert, F.; Dorny, P.; Vercruysse, J., Failure of mebendazole in treatment of human hook-worm infections in the southern region of Mali. Am. J. Trop. Med.Hyg., 1997, 57, 25-30.
30. Albonico, M.; Bickle, Q.; Ramsan, M.; Montresor, A.; Savioli, L.; Taylor, M., Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar. Bull. W.H.O., 2003,81, 343-52.
31. Albonico, M.; Wright, V.; Bickle, Q., Molecular analysis of the beta-tubulin gene of human hookworms as a basis for possible benzimidazole resistance on Pemba Island. Mol. Biochem. Parasitol.,2004, 134, 281-4.
32. Bennett, A. B.; Anderson, T. J.; Barker, G. C.; Michael, E.; Bundy, D. A., Sequence variation in the Trichuris trichiura beta-tubulin locus: implications for the development of benzimidazole resistance. Int. J. Parasitol., 2002, 32, 1519-28.
33. Hoti, S. L.; Dhamodharan, R.; Subramaniyan, K.; Das, P. K., Anallele specific PCR assay for screening for drug resistance among Wuchereria bancrofti populations in India. Ind. J. Med. Res., 2009,130, 193-9.
34. Hoti, S. L.; Subramaniyan, K.; Das, P. K., Detection of codon foramino acid 200 in isotype 1 beta-tubulin gene of Wuchereria ban-crofti isolates, implicated in resistance to benzimidazoles in other nematodes. Acta Trop., 2003, 88, 77-81.
35. Schwab, A. E.; Boakye, D. A.; Kyelem, D.; Prichard, R. K., Detection of benzimidazole resistance-associated mutations in the filarial nematode Wuchereria bancrofti and evidence for selection by albendazole and ivermectin combination treatment. Am. J. Trop.Med. Hyg., 2005, 73, 234-8.
36. Geary, T. G.; Nulf, S. C.; Alexander-Bowman, S. J.; Mahmoud, B.M.; Prichard, R. K.; Klein, R. D., Cloning and characterization of cDNAs encoding beta-tubulin from Dirofilaria immitis and On-chocerca volvulus. J. Parasitol., 1998, 84, 356-60.
37. Ryan, L. A.; Hoey, E.; Trudgett, A.; Fairweather, I.; Fuchs, M.; Robinson, M. W.; Chambers, E.; Timson, D. J.; Ryan, E.; Feltwell, T.; Ivens, A.; Bentley, G.; Johnston, D., Fasciola hepatica expresses multiple alpha- and beta-tubulin isotypes. Mol. Biochem.Parasitol., 2008, 159, 73-8.
38. Robinson, M. W.; Lawson, J.; Trudgett, A.; Hoey, E. M.; Fairweather, I., The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica. Parasitol. Res., 2004, 92, 205-10.
39. Geary, T. G.; Sims, S. M.; Thomas, E. M.; Vanover, L.; Davis, J.P.; Winterrowd, C. A.; Klein, R. D.; Ho, N. F.; Thompson, D. P.,Haemonchus contortus: ivermectin-induced paralysis of the pharynx. Exp. Parasitol., 1993, 77, 88-96.
40. Beech, R. N.; Wolstenholme, A. J.; Neveu, C.; Dent, J. A. Naminggenes in the parasitic nematodes. Trend Parasitol 2009, in press.
41. Cully, D.; Vassilatis, D.; Liu, K.; Paress, P.; Van, d. P. L.; Schaeffer, J.; Arena, J., Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nature 1994,371, 707-711.
42. Dent, J. A.; Smith, M. M.; Vassilatis, D. K.; Avery, L., The genetics of ivermectin resistance in Caenorhabditis elegans. Proc. Natl.Acad. Sci. USA, 2000, 97, 2674-9.
43. Cully, D. F.; Paress, P. S., Solubilization and characterization of a high affinity ivermectin binding site from Caenorhabditis elegans.Mol. Pharmacol., 1991, 40, 326-32.
44. Paiement, J.; Prichard, R. K.; Ribeiro, P., Haemonchus contortus:characterization of a glutamate binding site in unselected and ivermectin-selected larvae and adults. Exp. Parasitol., 1999, 92, 32-9.
45. Rohrer, S. P.; Birzin, E. T.; Eary, C. H.; Schaeffer, J. M.; Shoop, W. L., Ivermectin binding sites in sensitive and resistant Haemonchus contortus. J. Parasitol., 1994, 80, 493-7.
46. Delany, N. S.; Laughton, D. L.; Wolstenholme, A. J., Cloning andlocalisation of an avermectin receptor-related subunit from Haemonchus contortus. Mol. Biochem. Parasitol., 1998, 97, 177-87.
47. Forrester, S. G.; Hamdan, F. F.; Prichard, R. K.; Beech, R. N., Cloning, sequencing, and developmental expression levels of anovel glutamate-gated chloride channel homologue in the parasiticnematode Haemonchus contortus. Biochem. Biophys. Res. Commun., 1999, 254, 529-34.
48. Laughton, D. L.; Amar, M.; Thomas, P.; Towner, P.; Harris, P.; Lunt, G. G.; Wolstenholme, A. J., Cloning of a putative inhibitoryamino acid receptor subunit from the parasitic nematode Haemonchus contortus. Recept. Channel, 1994, 2, 155-63.
49. Taly, A.; Corringer, P. J.; Guedin, D.; Lestage, P.; Changeux, J. P., Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system. Nat. Rev. Drug Discov., 2009, 8, 733-50.
50. Amin, J.; Weiss, D. S., Homomeric rho 1 GABA channels: activation properties and domains. Recept. Channels, 1994, 2, 227-36.
51. Beech, R. N.; Levitt, N.; Cambos, M.; Zhou, S.; Forrester, S. G., Association of ion-channel genotype and macrocyclic lactone sensitivity traits in Haemonchus contortus. Mol. Biochem. Parasitol., 2009, in press.
52. Blackhall, W. J.; Pouliot, J. F.; Prichard, R. K.; Beech, R. N., Haemonchus contortus: selection at a glutamate-gated chloride channelgene in ivermectin- and moxidectin-selected strains. Exp. Parasitol., 1998, 90, 42-48.
53. Blackhall, W. J.; Prichard, R. K.; Beech, R. N., Selection at a gamma-aminobutyric acid receptor gene in Haemonchus contortus resistant to avermectins/milbemycins. Mol. Biochem. Parasitol.,2003, 131, 137-45.
54. Galazzo, D. A comparison of laboratory and field resistance tomacrocyclic lactones in Haemonchus contortus. MSc, McGill University, Montreal, 2004.
55. Blackhall, W. Genetic Variation and Ivermectin Resistance in Haemonchus contortus. PhD, McGill University, Montreal, 1999.
56. Njue, A. I.; Hayashi, J.; Kinne, L.; Feng, X. P.; Prichard, R. K., Mutations in the extra cellular domains of glutamate-gated chloride channel alpha3 and beta subunits from ivermectin-resistant Cooperia oncophora affect agonist sensitivity. J. Neurochem., 2004, 89,1137-47.
57. McCavera, S.; Rogers, A. T.; Yates, D. M.; Woods, D. J.; Wolstenholme, A. J., An ivermectin-sensitive glutamate-gated chloride channel from the parasitic nematode Haemonchus contortus. Mol.Pharmacol., 2009, 75, 1347-55.
58. Lewis, J. A.; Wu, C. H.; Berg, H.; Levine, J. H., The genetics of levamisole resistance in the nematode Caenorhabditis elegans. Genetics, 1980, 95, 905-28.
59. Qian, H.; Martin, R. J.; Robertson, A. P., Pharmacology of N-, L-,and B-subtypes of nematode nAChR resolved at the single-channel level in Ascaris suum. FASEB J., 2006, 20, 2606-8.
60. Qian, H.; Robertson, A. P.; Powell-Coffman, J. A.; Martin, R. J., Levamisole resistance resolved at the single-channel level in Caenorhabditis elegans. FASEB J., 2008, 22, 3247-54.
61. Ballivet, M.; Alliod, C.; Bertrand, S.; Bertrand, D., Nicotinic acetylcholine receptors in the nematode Caenorhabditis elegans. J. Mol. Biol., 1996, 258, 261-9.
62. Williamson, S. M.; Robertson, A. P.; Brown, L.; Williams, T.; Woods, D. J.; Martin, R. J.; Sattelle, D. B.; Wolstenholme, A. J., The nicotinic acetylcholine receptors of the parasitic nematode Ascaris suum: formation of two distinct drug targets by varying the relative expression levels of two subunits. PLoS Pathog., 2009, 5,e1000517.
63. Robertson, A. P.; Bjorn, H. E.; Martin, R. J., Resistance to levamisole resolved at the single-channel level. FASEB J., 1999, 13, 749-60.
64. Neveu, C.; Charvet, C.; Fauvin, A.; Cortet, J.; Beech, R.; Cabaret, J., Genetic diversity of levamisole receptor subunits in parasitic nematodes and abbreviated transcripts associated with resistance. Pharm. Gen., 2010, Accepted.
65. Rufener, L.; Maser, P.; Roditi, I.; Kaminsky, R., Haemonchuscontortus acetylcholine receptors of the DEG-3 subfamily and their role in sensitivity to mone pantel. PLoS Pathog., 2009, 5, e1000380.
66. Kaminsky, R.; Ducray, P.; Jung, M.; Clover, R.; Rufener, L.; Bouvier, J.; Weber, S. S.; Wenger, A.; Wieland-Berghausen, S.; Goebel, T.; Gauvry, N.; Pautrat, F.; Skripsky, T.; Froelich, O.; Komoin-Oka, C.; Westlund, B.; Sluder, A.; Maser, P., A new class of anthelmintics effective against drug-resistant nematodes. Nature,2008, 452, 176-80.
67. Rao, V. T.; Siddiqui, S. Z.; Prichard, R. K.; Forrester, S. G., Adopamine-gated ion channel (HcGGR3*) from Haemonchus contortus is expressed in the cervical papillae and is associated with macro cyclic lactone resistance. Mol. Biochem. Parasitol., 2009,166, 54-61.
68. Saragoza, P. A.; Modir, J. G.; Goel, N.; French, K. L.; Li, L.; Nowak, M. W.; Stitzel, J. A., Identification of an alternatively processed nicotinic receptor alpha7 subunit RNA in mouse brain. Mol. Brain Res., 2003, 117, 15-26.
69. Jones, A. K.; Davis, P.; Hodgkin, J.; Sattelle, D. B., The nicotinic acetylcholine receptor gene family of the nematode Caenorhabditis elegans: an update on nomenclature. Invert. Neurosci., 2007, 7,129-31.
70. Jones, A. K.; Sattelle, D. B., The cys-loop ligand-gated ion channel gene superfamily of the nematode, Caenorhabditis elegans. Invert.Neurosci., 2008, 8, 41-7.
71. Cioli, D.; Pica-Mattoccia, L., Praziquantel. Parasitol. Res., 2003, 90, S3-9.
72. Cioli, D., Chemotherapy of schistosomiasis: an update. Parasitol.Today, 1998, 14, 418-22.
73. Kohn, A. B.; Anderson, P. A.; Roberts-Misterly, J. M.; Greenberg, R. M., Schistosome calcium channel beta subunits. Unusual modulatory effects and potential role in the action of the antischistosomal drug praziquantel. J. Biol. Chem., 2001, 276, 36873-6.
74. Kohn, A. B.; Roberts-Misterly, J. M.; Anderson, P. A.; Greenberg, R. M., Creation by mutagenesis of a mammalian Ca(2+) channel beta subunit that confers praziquantel sensitivity to a mammalianCa(2+) channel. Int. J. Parasitol., 2003, 33, 1303-8.
75. Kohn, A. B.; Roberts-Misterly, J. M.; Anderson, P. A.; Khan, N.; Greenberg, R. M., Specific sites in the Beta Interaction Domain ofa schistosome Ca2+ channel beta subunit are key to its role in sensitivity to the anti-schistosomal drug praziquantel. Parasitology 2003, 127, 349-56.
76. Ismail, M.; Botros, S.; Metwally, A.; William, S.; Farghally, A.; Tao, L. F.; Day, T. A.; Bennett, J. L., Resistance to praziquantel:direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am. J. Trop. Med. Hyg., 1999, 60, 932-5.
77. 2+ channel regulation by a conserved beta subunit domain. Neuron, 1994, 13, 495-503.
78. Valle, C.; Troiani, A. R.; Festucci, A.; Pica-Mattoccia, L.; Liberti, P.; Wolstenholme, A.; Francklow, K.; Doenhoff, M. J.; Cioli, D., Sequence and level of endogenous expression of calcium channel beta subunits in Schistosoma mansoni displaying different susceptibilities to praziquantel. Mol. Biochem. Parasitol., 2003, 130, 111-5.